Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases
Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases
Recruiting · NCT05481658 · Registry updated 2026-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases | Cutaneous Metastases | Recruiting | Phase 1 | 2026-02-10 | NCT05481658 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nicholas Gulati | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |